“Risk factors for preeclampsia in healthy nulliparous women.”, Am J Obstet Gynecol, vol. 177, pp. 1003-10, 1997.
, “Prednisone Withdrawal in Kidney Transplant Recipients on Cyclosporine and Mycophenolate Mofetil - A Prospective Randomized Study”, Transplantation, vol. 12, no. 68, pp. 1865-1874, 1999.
, “No Evidence for Lipid Peroxidation in Severe Preeclampsia”, Am J Obstet Gynecol, vol. 185, no. 3, pp. 572-678, 2001.
, “Economic Analysis of Unrelated Allogeneic Bone Marrow Transplantation: Results From The Randomized Clinical Trial of T-Cell Depletion vs Unmanipulated Grafts for the Prevention of Graft-Versus-Host Disease”, Bone Marrow Transplant, vol. 36, pp. 539-546, 2005.
, “Twenty-Four Hour Urine Insulin as a Measure of Hyperinsulinaemia/Insulin Resistance Before Onset of Pre-Eclampsia and Gestational Hypertension”, BJOG, vol. 112, pp. 1471-1528, 2005.
, “The Effect of Unrelated Donor Marrow Transplantation on Health-Related Qualify of Life: A Report of the Unrelated Donor Marrow Transplantation Trial (T-cell Depletion Trial)”, Biol Blood Marrow Transplant, vol. 12, pp. 648-655, 2006.
, “Comparative Immunogenicity of Trivalent Influenza Vaccine Administered by Intradermal or Intramuscular Route in Healthy Adults”, Vaccine, vol. 25, pp. 6755-6763, 2007.
, “Autologous vs. Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Follicular Non-Hodgkins Lymphoma (FL) Beyond First Complete Response or First Partial Response”, in American Society of Clinical Oncology Annual Meeting, Chicago, IL, 2008.
, “Use of Biological Assignment in Hematopoietic Stem Cell Transplantation Clinical Trials”, Clin Trials, vol. 5, pp. 607-616, 2008.
, “Autologous vs. Reduced Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Chemosensitive Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response or First Partial Response”, Biol Blood Marrow Transplant, vol. 17, pp. 1051-1057, 2011.
, “Fludarabine-Based Conditioning for Marrow Transplantation From Unrelated Donors in Severe Aplastic Anemia: Early Results of a Cyclophosphamide Dose De-Escalation Study Show Life-Threatening Adverse Events at Predefined Cyclophosphamide Dose Levels”, Biol Blood Marrow Transplant, vol. 18, pp. 1007-1011, 2012.
, “Correlate of Immune Protection Against HSV-1 Genital Disease in Vaccinated Women”, J Infect Dis, vol. 209, pp. 828-836, 2014.
, “HSV-1 and HSV-2 Seroprevalence in the United States Among Asymptomatic Women Unaware of any Herpes Simplex Virus Infection (Herpevac Trial for Women)”, Southern Medical Journal, vol. 107, pp. 79-84, 2014.
,